Shares of Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) dropped 1.5% on Thursday . The stock traded as low as $0.12 and last traded at $0.12. Approximately 5,001 shares changed hands during trading, a decline of 83% from the average daily volume of 29,254 shares. The stock had previously closed at $0.12.
Guided Therapeutics Trading Down 1.5 %
The company’s fifty day simple moving average is $0.14 and its two-hundred day simple moving average is $0.15.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Articles
- Five stocks we like better than Guided Therapeutics
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks About to Book Gains on Building Products Demand
- Pros And Cons Of Monthly Dividend Stocks
- Consumer Spending and Sentiment Rises: Time to Buy the XLY?
- With Risk Tolerance, One Size Does Not Fit All
- Is Estée Lauder on the Verge Of a Massive Comeback?
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
